Spravato (esketamine)

Spravato (esketamine) is an innovative, FDA-approved treatment designed to provide rapid relief for individuals with treatment-resistant depression. At Dr. Shiekh's practice, we are committed to offering the latest advancements in mental health care to help you achieve a brighter, healthier future.

Ready to experience the benefits of Spravato? Contact us at 214-461-9363 to schedule a consultation.

How Spravato Works

Spravato (esketamine) is a nasal spray that works differently from traditional antidepressants by targeting the NMDA receptors in the brain. This innovative treatment can provide rapid relief from depressive symptoms, often within hours of administration.

Scientific Background: Spravato is derived from ketamine, an anesthetic known for its antidepressant effects. By modulating the activity of NMDA receptors, Spravato helps restore neural connections in the brain, leading to improved mood and cognitive function. According to the FDA, Spravato is specifically approved for adults with treatment-resistant depression.


The Spravato Procedure:

  1. Initial Consultation: Dr. Shiekh will conduct a thorough evaluation to determine if Spravato is suitable for you.

  2. Treatment Sessions: Spravato is administered in-office under medical supervision. Patients are monitored for two hours after each session to ensure safety and assess response.

  3. Follow-Up Care: Regular follow-up appointments are scheduled to monitor progress and adjust treatment as needed.

Benefits of Spravato Therapy:

  • Rapid onset of antidepressant effects

  • Effective for treatment-resistant depression

  • Administered under medical supervision for safety

Discover the rapid relief of Spravato therapy. Call 214-461-9363 to learn more and schedule your consultation.


Spravato Therapy for Treatment-Resistant Depression

Treatment-resistant depression is a challenging condition that does not respond to traditional antidepressants. Spravato offers a new approach, providing hope for individuals who have struggled to find relief.

How Spravato Helps with Depression:

  • Targets NMDA receptors to restore neural connections

  • Rapidly reduces depressive symptoms

  • Provides an alternative for patients who have not responded to other treatments

Scientific Evidence: Clinical trials have demonstrated that Spravato significantly reduces depressive symptoms within hours of administration. A study published in the American Journal of Psychiatry reported a 70% response rate in patients receiving Spravato .

Patient Success Stories: Hear from our patients who have experienced the life-changing effects of Spravato therapy.

Don't let treatment-resistant depression define your life. Reach out to Dr. Shiekh at 214-461-9363 to find out if Spravato is right for you.

Frequently Asked Questions about Spravato Therapy

  • What is Spravato?

    • Spravato (esketamine) is a nasal spray approved by the FDA for the treatment of treatment-resistant depression.

  • How Does Spravato Work?

    • Spravato targets NMDA receptors in the brain, helping to restore neural connections and rapidly reduce depressive symptoms.

  • Is Spravato Safe?

    • Yes, Spravato is administered under medical supervision to ensure patient safety. Common side effects include dizziness, nausea, and increased blood pressure, which are monitored during the treatment session.

  • Who is a Candidate for Spravato Therapy?

    • Spravato is suitable for adults with treatment-resistant depression who have not responded to at least two different antidepressant treatments.

  • Does Insurance Cover Spravato Therapy?

    • Dr. Shiekh is credentialed with BCBS TX and Tricare. Please contact our office to discuss insurance coverage and payment options.

  • For more questions, or to schedule a consultation, call us at 214-461-9363. We're here to help you explore the benefits of Spravato therapy.